Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
Regulatory T cells, which help to dampen inflammation, are being used in clinical trials against ailments such as rheumatoid ...
In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels ...
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For patients whose cancer returns or is treatment-refractory, choices are ...
Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...
MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...
In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback